100 related articles for article (PubMed ID: 23265700)
1. Systemic therapy of advanced non-small cell lung cancer: major-developments of the last 5-years.
Cufer T; Ovcaricek T; O'Brien ME
Eur J Cancer; 2013 Apr; 49(6):1216-25. PubMed ID: 23265700
[TBL] [Abstract][Full Text] [Related]
2. Recent trends in the treatment of advanced lung cancer.
Saijo N
Cancer Sci; 2006 Jun; 97(6):448-52. PubMed ID: 16734721
[TBL] [Abstract][Full Text] [Related]
3. Refining the treatment of advanced nonsmall cell lung cancer.
Ogita S; Wozniak AJ
Lung Cancer (Auckl); 2010; 1():9-22. PubMed ID: 28210103
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa preparation plus chemotherapy for advanced non-small-cell lung cancer: a randomized, multicenter, double-blind phase III study.
Chang J; Liu Y; Han B; Zhou C; Bai C; Li J
Med Oncol; 2015 May; 32(5):139. PubMed ID: 25801231
[TBL] [Abstract][Full Text] [Related]
5. MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma.
Xu H; Du Z; Li Z; Liu X; Li X; Zhang X; Ma J
Ann Med; 2024 Dec; 56(1):2313671. PubMed ID: 38325364
[TBL] [Abstract][Full Text] [Related]
6. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.
Lai J; Lin X; Zheng H; Xie B; Fu D
BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study on immune-related pneumonitis in patients with non-small-cell lung cancer undergoing treatment with PD-1/PD-L1 inhibitors.
Yakymenko D; Skougaard K
Eur Clin Respir J; 2023; 10(1):2194162. PubMed ID: 37025977
[TBL] [Abstract][Full Text] [Related]
8. Combined model of radiomics, clinical, and imaging features for differentiating focal pneumonia-like lung cancer from pulmonary inflammatory lesions: an exploratory study.
Gong JW; Zhang Z; Luo TY; Huang XT; Zhu CN; Lv JW; Li Q
BMC Med Imaging; 2022 May; 22(1):98. PubMed ID: 35610588
[TBL] [Abstract][Full Text] [Related]
9. Identifying pathological subtypes of non-small-cell lung cancer by using the radiomic features of
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
Transl Cancer Res; 2019 Sep; 8(5):1741-1749. PubMed ID: 35116924
[TBL] [Abstract][Full Text] [Related]
10. The Challenge of Choosing the Best Classification Method in Radiomic Analyses: Recommendations and Applications to Lung Cancer CT Images.
Corso F; Tini G; Lo Presti G; Garau N; De Angelis SP; Bellerba F; Rinaldi L; Botta F; Rizzo S; Origgi D; Paganelli C; Cremonesi M; Rampinelli C; Bellomi M; Mazzarella L; Pelicci PG; Gandini S; Raimondi S
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205631
[TBL] [Abstract][Full Text] [Related]
11. Radiomics-Based Features for Prediction of Histological Subtypes in Central Lung Cancer.
Li H; Gao L; Ma H; Arefan D; He J; Wang J; Liu H
Front Oncol; 2021; 11():658887. PubMed ID: 33996583
[TBL] [Abstract][Full Text] [Related]
12. Improving the Subtype Classification of Non-small Cell Lung Cancer by Elastic Deformation Based Machine Learning.
Gao Y; Song F; Zhang P; Liu J; Cui J; Ma Y; Zhang G; Luo J
J Digit Imaging; 2021 Jun; 34(3):605-617. PubMed ID: 33963422
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15-39 Years): A Population-Based Study in The Netherlands 1990-2016.
van der Meer DJ; Karim-Kos HE; van der Mark M; Aben KKH; Bijlsma RM; Rijneveld AW; van der Graaf WTA; Husson O
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33218178
[TBL] [Abstract][Full Text] [Related]
14. Exploratory Study of a CT Radiomics Model for the Classification of Small Cell Lung Cancer and Non-small-Cell Lung Cancer.
Liu S; Liu S; Zhang C; Yu H; Liu X; Hu Y; Xu W; Tang X; Fu Q
Front Oncol; 2020; 10():1268. PubMed ID: 33014770
[No Abstract] [Full Text] [Related]
15. A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies.
Qu J; Wang L; Jiang M; Zhao D; Wang Y; Zhang F; Li J; Zhang X
Cancer Manag Res; 2020; 12():6493-6509. PubMed ID: 32801888
[TBL] [Abstract][Full Text] [Related]
16. Inhibition effect of miR-150 on the progression of oral squamous cell carcinoma by data analysis model based on independent sample T-test.
Wu C; Yang M; Chen H
Saudi J Biol Sci; 2020 Feb; 27(2):599-605. PubMed ID: 32210677
[TBL] [Abstract][Full Text] [Related]
17. Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets.
Choi KH; Shin CH; Lee WJ; Ji H; Kim HH
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262974
[TBL] [Abstract][Full Text] [Related]
18. Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement, but Better Survival.
Suidan AM; Roisman L; Belilovski Rozenblum A; Ilouze M; Dudnik E; Zer A; Peled N
J Glob Oncol; 2019 May; 5():1-8. PubMed ID: 31067141
[No Abstract] [Full Text] [Related]
19. Long Non-coding RNA PVT1 Competitively Binds MicroRNA-424-5p to Regulate CARM1 in Radiosensitivity of Non-Small-Cell Lung Cancer.
Wang D; Hu Y
Mol Ther Nucleic Acids; 2019 Jun; 16():130-140. PubMed ID: 30861415
[TBL] [Abstract][Full Text] [Related]
20. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.
Qiu X; Chen D; Liu Y; Duan S; Zhang F; Zhang Y; Li F; Chen C; Chen Y
Thorac Cancer; 2019 Feb; 10(2):256-267. PubMed ID: 30605235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
